Literature DB >> 4812446

Metabolic clearance and production rates of human thyrotropin.

E C Ridgway, B D Weintraub, F Maloof.   

Abstract

Metabolic clearance (MCR) and production rates (PR) of human thyrotropin (hTSH) were determined by the constant infusion to equilibrium method 57 times in 55 patients. 16 control patients had a mean hTSH MCR of 50.7 ml/min. The mean hTSH MCR was significantly (P < 0.02) higher in 19 euthyroid men (51.6 ml/min) than in 12 euthyroid women (43.0 ml/min), but this apparent sex difference disappeared when the MCR were corrected for surface area, 25.8 (men) versus 25.2 ml/min per m(2) (women). Hypothyroid patients had significantly (P < 0.005) lower hTSH MCR (30.9 ml/min), and hyperthyroid patients had significantly (P < 0.05) higher hTSH MCR (60.9 ml/min) than controls. The hTSH MCR in patients with "decreased thyroid reserve" (40.9 ml/min), hyperfunctioning thyroid nodule (53.8 ml/min), and "empty sella syndrome" (46.6 ml/min) were not significantly different from controls. The mean hTSH PR in controls (104.3 mU/day) was significantly (P < 0.005) different from that in patients with "decreased thyroid reserve" (956 mU/day), hypothyroidism (4,440 mU/day), hyperthyroidism (< 43.9 mU/day) and a hyperfunctioning thyroid nodule (< 38.7 mU/day). In primary hypothyroidism intravenous triiodothyronine therapy (50 mug/day) for 10 days decreased the hTSH PR (from 4,244 to 2,461 mU/day) before changes in the hTSH MCR (from 33.1 to 33.7 mU/day) were observed. These studies have demonstrated that changes in the serum concentration of hTSH are mainly due to altered pituitary hTSH secretion with only a minor contribution from the change in hTSH MCR.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812446      PMCID: PMC333072          DOI: 10.1172/JCI107630

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Disappearance rate of exogenous thyroid-stimulating hormone (TSH) in man.

Authors:  J BAKKE; N LAWRENCE; S ROY
Journal:  J Clin Endocrinol Metab       Date:  1962-04       Impact factor: 5.958

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Disappearance rate of exogenous thyrotrophin from the blood of normal and hypophysectomized rats.

Authors:  S A D'ANGELO
Journal:  Endocrinology       Date:  1951-03       Impact factor: 4.736

4.  Plasma ACTH determinations in 58 patients before or after adrenalectomy for Cushing's syndrome.

Authors:  D H Nelson; J G Sprunt; R B Mims
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

5.  Circadian variations of serum thyrotropin levels in man.

Authors:  L Vanhaelst; E Van Cauter; J P Degaute; J Golstein
Journal:  J Clin Endocrinol Metab       Date:  1972-09       Impact factor: 5.958

6.  Utility of the radioimmunoassay of serum thyrotrophin in man.

Authors:  J M Hershman; J A Pittman
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

7.  Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women.

Authors:  P O Kohler; G T Ross; W D Odell
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

8.  Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function.

Authors:  W E Mayberry; H Gharib; J M Bilstad; G W Sizemore
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

9.  Estimation of the secretion rate of thyrotropin in man.

Authors:  W D Odell; R D Utiger; J F Wilber; P G Condliffe
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

10.  Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women.

Authors:  Y D Coble; P O Kohler; C M Cargille; G T Ross
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

View more
  11 in total

1.  Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.

Authors:  Jeremy A Leonard; Yu-Mei Tan; Mary Gilbert; Kristin Isaacs; Hisham El-Masri
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

2.  TSH regulation dynamics in central and extreme primary hypothyroidism.

Authors:  Marisa C Eisenberg; Ferruccio Santini; Alessandro Marsili; Aldo Pinchera; Joseph J DiStefano
Journal:  Thyroid       Date:  2010-11       Impact factor: 6.568

3.  A kinetic study on secretion and elimination of endogenous thyrotropin in the thyrotropin-releasing hormone test.

Authors:  I Tsukamoto; K Satoh; K Kojima; I Hino; Y Kawase; H Seo; T Miyamoto; N Hosokawa; S Matsuno; T Tsukamoto
Journal:  Ann Nucl Med       Date:  1989-03       Impact factor: 2.668

4.  Metabolic and renal clearance rates of purified human chorionic gonadotropin.

Authors:  R E Wehmann; B C Nisula
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Metabolic clearance and secretion rates of subunits of human thyrotropin.

Authors:  I A Kourides; R N Re; B D Weintraub; E C Ridgway; F Maloof
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

7.  Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils.

Authors:  S A Weitzman; T P Stossel; D C Harmon; G Daniels; F Maloof; E C Ridgway
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.

Authors:  Marisa Eisenberg; Mary Samuels; Joseph J DiStefano
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

9.  Fetal hypophysis as the main source of serum TSH in fetal rat.

Authors:  P Pic; J P Bouquin; F el Atiq
Journal:  Experientia       Date:  1986-10-15

10.  Systems pharmacology modeling of drug-induced modulation of thyroid hormones in dogs and translation to human.

Authors:  Petra Ekerot; Douglas Ferguson; Eva-Lena Glämsta; Lars B Nilsson; Håkan Andersson; Susanne Rosqvist; Sandra A G Visser
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.